191 related articles for article (PubMed ID: 35945246)
21. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing.
Radvansky J; Ficek A; Kadasi L
Genet Test Mol Biomarkers; 2011 Mar; 15(3):133-6. PubMed ID: 21204698
[TBL] [Abstract][Full Text] [Related]
22. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
23. Massive contractions of myotonic dystrophy type 2-associated CCTG tetranucleotide repeats occur via double-strand break repair with distinct requirements for DNA helicases.
Papp D; Hernandez LA; Mai TA; Haanen TJ; O'Donnell MA; Duran AT; Hernandez SM; Narvanto JE; Arguello B; Onwukwe MO; Mirkin SM; Kim JC
G3 (Bethesda); 2024 Feb; 14(2):. PubMed ID: 37950892
[TBL] [Abstract][Full Text] [Related]
24. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.
Kurosaki T; Ueda S; Ishida T; Abe K; Ohno K; Matsuura T
PLoS One; 2012; 7(6):e38379. PubMed ID: 22723857
[TBL] [Abstract][Full Text] [Related]
25. Dominantly inherited, non-coding microsatellite expansion disorders.
Ranum LP; Day JW
Curr Opin Genet Dev; 2002 Jun; 12(3):266-71. PubMed ID: 12076668
[TBL] [Abstract][Full Text] [Related]
26. [A pedigree with myotonic dystrophy: non-CTG, non-CCTG repeat expansion].
Zhao XP; Xie HJ; Zheng HM; Yu ZL; Cui Y; Ding SJ; Ren DM; Tang GM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):459-62. PubMed ID: 15476170
[TBL] [Abstract][Full Text] [Related]
27. Unusual structures of CCTG repeats and their participation in repeat expansion.
Guo P; Lam SL
Biomol Concepts; 2016 Dec; 7(5-6):331-340. PubMed ID: 27879482
[TBL] [Abstract][Full Text] [Related]
28. Rapid detection of large expansions in progressive myoclonus epilepsy type 1, myotonic dystrophy type 2 and spinocerebellar ataxia type 8.
Krysa W; Rajkiewicz M; Sułek A
Neurol Neurochir Pol; 2012; 46(2):113-20. PubMed ID: 22581592
[TBL] [Abstract][Full Text] [Related]
29. Myotonic Dystrophies: A Genetic Overview.
Soltanzadeh P
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205411
[TBL] [Abstract][Full Text] [Related]
30. Upgrading molecular diagnostics of myotonic dystrophies: multiplexing for simultaneous characterization of the DMPK and ZNF9 repeat motifs.
Radvansky J; Ficek A; Kadasi L
Mol Cell Probes; 2011 Aug; 25(4):182-5. PubMed ID: 21550396
[TBL] [Abstract][Full Text] [Related]
31. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2).
Sallinen R; Vihola A; Bachinski LL; Huoponen K; Haapasalo H; Hackman P; Zhang S; Sirito M; Kalimo H; Meola G; Horelli-Kuitunen N; Wessman M; Krahe R; Udd B
Neuromuscul Disord; 2004 Apr; 14(4):274-83. PubMed ID: 15019706
[TBL] [Abstract][Full Text] [Related]
32. Myotonic dystrophy type 2: the 2020 update.
Meola G
Acta Myol; 2020 Dec; 39(4):222-234. PubMed ID: 33458578
[TBL] [Abstract][Full Text] [Related]
33. Hairpin structure-forming propensity of the (CCTG.CAGG) tetranucleotide repeats contributes to the genetic instability associated with myotonic dystrophy type 2.
Dere R; Napierala M; Ranum LP; Wells RD
J Biol Chem; 2004 Oct; 279(40):41715-26. PubMed ID: 15292165
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a New Molecular Diagnostic Assay for Detection of Myotonic Dystrophy Type 2.
Valaperta R; Lombardi F; Cardani R; Fossati B; Brigonzi E; Merli I; Sansone V; Merletti G; Spina E; Meola G; Costa E
Genet Test Mol Biomarkers; 2015 Dec; 19(12):703-9. PubMed ID: 26505324
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of Non-Pathogenic Premutation-Range Myotonic Dystrophy Type 2 Alleles.
Radvanszky J; Hyblova M; Radvanska E; Spalek P; Valachova A; Magyarova G; Bognar C; Polak E; Szemes T; Kadasi L
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501382
[TBL] [Abstract][Full Text] [Related]
36. Reduction of Cellular Nucleic Acid Binding Protein Encoded by a Myotonic Dystrophy Type 2 Gene Causes Muscle Atrophy.
Wei C; Stock L; Schneider-Gold C; Sommer C; Timchenko NA; Timchenko L
Mol Cell Biol; 2018 Jul; 38(14):. PubMed ID: 29735719
[TBL] [Abstract][Full Text] [Related]
37. Myotonic dystrophies.
Huang CC; Kuo HC
Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic analysis of the first known Asian family with myotonic dystrophy type 2.
Nakayama T; Nakamura H; Oya Y; Kimura T; Imahuku I; Ohno K; Nishino I; Abe K; Matsuura T
J Hum Genet; 2014 Mar; 59(3):129-33. PubMed ID: 24430576
[TBL] [Abstract][Full Text] [Related]
39. Sporadic Myotonic Dystrophy Type 2 in a Japanese Patient.
Miyashita K; Ii Y; Matsuyama H; Niwa A; Kawana Y; Shibata S; Minami N; Nishino I; Tomimoto H
Intern Med; 2023 Oct; 62(20):3027-3031. PubMed ID: 36792202
[TBL] [Abstract][Full Text] [Related]
40. Ancestral Origin of the First Indian Families with Myotonic Dystrophy Type 2.
Damen M; Schijvenaars M; Schimmel-Naber M; Groothuismink J; Coenen M; Tieleman A
J Neuromuscul Dis; 2021; 8(4):715-722. PubMed ID: 34024776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
